Stay updated on COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Sign up to get notified when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.

Latest updates to the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNew site revision tag appears: Revision: v3.5.4 has been added, replacing Revision: v3.5.3. This indicates a routine upgrade to the site's underlying version.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s displayed interface revision/version is updated from v3.5.2 to v3.5.3, indicating a system release on ClinicalTrials.gov rather than a change to the trial’s record history.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study history.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision metadata updated: v3.4.3 added and v3.4.2 removed.SummaryDifference0.0%

- Check112 days agoChange DetectedRevision: v3.4.2 was added to the history list. The notice about government funding operating status and the earlier revision v3.4.1 were removed.SummaryDifference0.3%

Stay in the know with updates to COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Enter your email address, and we'll notify you when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.